Latest News

April 25, 2002
The UCSF-San Francisco General Hospital Medical Center Family Practice Residency Program will celebrate 30 years of teaching family physicians how to provide quality care for urban, underserved communities with an open house at the Family Health Center.  The open house will be held from 4-5:30 pm on Saturday, April 27 at the program’s main training site, the SFGHMC Family Health Center, 1001 Potrero Ave., Building 80.
April 24, 2002
UCSF Public Service Programs expects more than 425 youngsters at Take Our Daughters to Work Day, 2002 on Thursday, April 25 from 8:30-11:45 am.  Both daughters and sons have enrolled in the campus-wide program sponsored by the Department of Public Affairs with contributions from the UCSF Center for Gender Equity, UCSF Medical Center and the Schools of Dentistry, Medicine, Nursing, Pharmacy and the Graduate Division. The free program is celebrating its 10th year anniversary by the Ms. Foundation and is booked to capacity at UCSF.  This year, events will include:
April 21, 2002
The most common cause of sudden death in young athletes - a heart condition known as hypertrophic cardiomyopathy - can develop from a single genetic mutation that disrupts at least two other genes, interfering with the normal beating of the heart, UCSF-led research suggests. All three genes encode contractile proteins that interact in heart muscle.
January 15, 2002
In a study of more than 3,000 infants with fevers, UCSF researchers found that there is a higher risk for urinary tract infections in uncircumcised boys compared with girls and circumcised boys.  The comparisons were 18 percent for uncircumcised boys, 11 percent for girls and two percent for circumcised boys.
January 15, 2002
Chinese-American smokers draw in less nicotine per cigarette and also metabolize nicotine more slowly than Latinos and other Caucasians, helping explain why they tend to smoke less than most Caucasians and have relatively low rates of lung cancer, UCSF scientists have found. The finding supports growing evidence that ethnicity can significantly affect people’s response to drugs and should be taken into account in developing and prescribing drugs, according to the researchers.
January 14, 2002
Saul Perlmutter, PhD, senior scientist at the E.O. Lawrence Berkeley National Laboratory and the Center for Particle Astrophysics at UC Berkeley, will present the 8th Annual Galante Lecture at 3 pm on Thursday, January 24 at UCSF in Cole Hall, 513 Parnassus Avenue.  Perlmutter will speak on the subject “Supernovas, Dark Energy and the Accelerating Universe——What Next?”  The lecture is free and open to the public.
January 11, 2002
Did you know that 30 minutes of your time and one unit of your blood can help save up to three lives?  Jean Katz, RN, BSN, PHN, clinical nurse supervisor of the UCSF Blood Donor Center, said that most people don’t realize how precious the gift of blood is or how important this contribution is to our community.  “I call blood donations ‘liquid gold’ and know that more people would donate blood if they had an understanding of how important one unit can be,” Katz said.
January 11, 2002
Children improperly restrained in toddler and infant car seats are at risk to be injured, according to a recent study by investigators at the San Francisco Injury Center (SFIC). The researchers note that it is likely that similar installation errors will occur with booster seats. New regulations mandate booster seats for children up to age six or weighing up to 60 pounds.
January 08, 2002
## KS-ASSOCIATED HERPESVIRUS EPIDEMIC IN SF GAY MEN PREDATES HIV EPIDEMIC, UCSF STUDY FINDS A high percentage of San Francisco gay men were infected with Kaposi’s sarcoma-associated herpesvirus (KSHV), the virus that causes Kaposi’s sarcoma (KS), in 1978 before the onset of the HIV epidemic, , according to UCSF researchers.
January 08, 2002
A common osteoporosis drug can reduce breast cancer in postmenopausal women with high estrogen levels, but produces no reduction in risk for women whose estrogen levels are very low, according to a UCSF study. Researchers found that raloxifene administered to a selected population of women reduced their rate of breast cancer by 76 percent. The study was published in the January 9 issue of the Journal of the American Medical Association (JAMA).